跳到内容
★ 登录后关注
AC

Andrew Chapman Date of appointment 6 May 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

董事
RGT
申报总数
1
公司
1
▲ 买入(0 笔)
—
▼ 卖出(0 笔)
—

最新申报发布于 2026年5月05日(RGT)。

Andrew Chapman Date of appointment 6 May 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust:交易记录概览

一笔交易,一个日期:2026年5月5日,Andrew Chapman Date of appointment 6 May 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust申报了在Argent BioPharma Limited的一笔交易。目前尚无更长的历史。以上数据均来自ASX发布的申报,描述的是过去的情况,不代表未来股价走势,也不构成投资建议。

与 Andrew Chapman Date of appointment 6 May 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust 相关的公司和市场

打开公司页面,查看内部人交易、基本面数据以及分析师一致预期(如有)。

申报1 总计

1 条申报中的 1 条